Task C1: A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Phase 1 Study of SARS-CoV-2 Therapeutics
$219,169N01FY2024AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.
View original record on NIH RePORTER →